'Targeting' the epidermal growth factor receptor tyrosine kinase with gefitinib (Iressa) in non-small cell lung cancer (NSCLC).

Pao W, Miller VA, Kris MG
Semin Cancer Biol. 2004 14 (1): 33-40

PMID: 14757534 · DOI:10.1016/j.semcancer.2003.11.005

MeSH Terms (8)

Animals Carcinoma, Non-Small-Cell Lung Clinical Trials as Topic ErbB Receptors Gefitinib Humans Lung Neoplasms Quinazolines

Connections (1)

This publication is referenced by other Labnodes entities: